highlights and progress

Year 4 BC-DOI NETWORK TEAM 1 SUMMARY

• The BC-DOI network (Team 1) is comprised of 6 core academic members, who utilize the infrastructure of 5 NCI comprehensive cancer centers, 4 NCRR P41 Technology Centers, and 2 NCI P01 program projects.
• Team 1 includes 41 Associate Members from 10 Academic and 11 Industry sites.
• Almost 35 students have participated in Team 1 organized meetings in the past year.
• The BC-DOI network organized 2 scientific sessions at national meetings, held 4 Executive Committee Conference calls, and presented at 4 international scientific meetings and 2 NIH sponsored meetings (13th Annual SPORE and NCI NTROI Meeting).
• Team 1 Investigators gave 32 presentations about research progress at 8 scientific meetings.
• Team 1 investigators filed 1 patent disclosure during this report period, and 3 patents are pending.
• Over 100 scientists, clinicians, students, and members of industry from 7 states and 3 countries attended our Fourth Annual BC-DOI Network Retreat, presenting 22 posters and 21 talks. Retreat talks are available on the Team 1 file exchange, http://www.bli.uci.edu/file-exchange-ntroi/index.php
• Team 1 conducted a training session for 22 clinicians, scientists, and students on the use of the Laser Breast Scanner (LBS) instrument. This session, lasting two days, detailed theory of operation, hardware, models and technical pitfalls. Training materials are available on the Team 1 file exchange http://www.bli.uci.edu/file-exchange-ntroi/index.php.
• Team 1 Investigators submitted 21 proposals to various agencies with the aim of leveraging NTROI funding.
• Team 1 clinical sites enrolled a total of 310 patients in BC-DOI network studies.
• Team 1 awarded 9 developmental projects with $250,000 in total costs to continue work towards specific aims. The awarded developmental projects, aimed at contributing new understanding to primary objectives of the RFA, translation and validation, cover a broad spectrum of activities including database development, standardization of histopathology methods, development of novel measurement protocols, and support for student training.
• Team 1 Investigators cited the NTROI in 56 publications.